WallStSmart
MREO

Mereo BioPharma Group PLC ADR

NASDAQ: MREO · HEALTHCARE · BIOTECHNOLOGY

$0.24
-1.53% today

Updated 2026-06-03

Market cap
$49.99M
P/E ratio
P/S ratio
99.99x
EPS (TTM)
$-0.20
Dividend yield
52W range
$0 – $3
Volume
3.7M

Mereo BioPharma Group PLC ADR (MREO) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+51.7%
Most recent quarter

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+2.7%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+7.0%
2026-05-12
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-05-12$-0.01+43.4%$0.24$0.26+7.0%
2026-03-19$-0.01-7.1%$0.35$0.34-2.8%
2025-11-10$-0.01-175.2%$1.80$1.87+3.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-0.01$-0.01+43.4%
2025-12-31$-0.01$-0.01-7.1%
2025-09-30$0.01$-0.01-175.2%
2025-06-30$-0.02$-0.02+17.7%$500000.00
2025-03-31$-0.01$-0.02-37.3%
2024-12-31$-0.01$-0.01+0.0%$1.06M+6.4%
2024-09-30$-0.02$-0.02+0.0%
2024-06-30$-0.01$-0.09-762.0%
2024-03-31$-0.01$-0.06-539.0%
2023-12-31$-0.02$-0.02+25.0%$1.00M
2023-09-30$0.00$0.00$533429.00

Frequently asked questions

Has Mereo BioPharma Group PLC ADR beaten earnings estimates?

Mereo BioPharma Group PLC ADR has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports. A consistent beat record suggests management guides conservatively and the business has predictable momentum, which tends to support the stock through earnings season.

How does MREO stock react to earnings?

MREO has moved an average of +2.7% the day after earnings over its last 3 reports, finishing higher after 2 of them. Next-day moves show how the market digests results in the short term, and repeated dips on strong reports usually mean expectations were already priced in.